Riskpilot← Back to searchSign inGet full accessSpraino Holding ApS
APSIn liquidationCVR 37626023Pilestræde 58, 6.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2016— employees
Revenue 2024
DKK -133K
+764% vs 2023
EBITDA margin
100.0%
-764% vs 2023
Equity ratio
-628.5%
Financial strength
Net profit 2024
DKK -962K
-12% vs 2023
| Revenue | DKK -133K | +764% |
| EBITDA | DKK -133K | -764% |
| Net profit | DKK -962K | -12% |
| Total assets | DKK 500K | -63% |
| Equity | DKK -3,1M | -44% |
| Employees | — | — |
Legal name
Spraino Holding ApS
CVR number
37626023
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
18. april 2016
Share capital
DKK 231.155
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Company purpose
Selskabets formål er at udvikle og kommercialisere en teknologisk platform til forebyggelse af ankelskader, samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Address
Pilestræde 58, 6.
Phone
+4533347404
Email
ahh@njordlaw.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -9 | -15 | -7 | -15 | -12 | -13 | -23 | -15 | -133 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -9 | -15 | -7 | -15 | -12 | -13 | -23 | -15 | -133 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9 | -15 | -7 | -15 | -12 | -13 | -23 | -15 | -133 |
| Net financials | -586 | -1.206 | -1.575 | -2.552 | -1.772 | -1.794 | -1.355 | -845 | -829 |
| Profit before tax | -595 | -1.221 | -1.582 | -2.567 | -1.784 | -1.807 | -1.377 | -860 | -962 |
| Tax | 1 | 8 | 6 | 12 | -0 | -43 | -25 | -0 | -0 |
| Net profit | -596 | -1.230 | -1.587 | -2.579 | -1.784 | -1.764 | -1.352 | -860 | -962 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 308 | 820 | 1.738 | 954 | 3.279 | 1.780 | 1.905 | 1.338 | 500 |
| Equity | 304 | 807 | 1.720 | 416 | -1.367 | -3.131 | -1.318 | -2.178 | -3.140 |
| Long-term debt | 0 | 8 | 0 | 0 | 4.638 | 2.796 | 2.996 | 3.169 | 0 |
| Short-term debt | 4 | 4 | 18 | 538 | 9 | 2.115 | 228 | 347 | 3.640 |
| Total debt | 4 | 13 | 18 | 538 | 4.647 | 4.911 | 3.224 | 3.516 | 3.640 |
EBITDA margin
-13331100.0%
This company
15.8%
Market median
-84374151% vs market
20162024
Equity ratio
-628.5%
This company
38.2%
Market median
-1745% vs market
20162024
Return on equity
-96226500.0%
This company
18.4%
Market median
-522970209% vs market
20162024
Net profit margin
-96226500.0%
This company
8.1%
Market median
-1187981581% vs market
20162024
Asset turnover
-0.27×
This company
1.12×
Market median
-124% vs market
20162024
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-04-18 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Unofficial title | Unofficial title | 2025 | — | — |
TB Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2016 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2018 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
GROENLYKKE MEDICAL ApS | Company | 33.3% | 33.3% | 2022 |
Mjinvest ApS | Company | 15.0% | 15.0% | 2020 |
SIPADAN ApS | Company | 10.0% | 10.0% | 2020 |
QUORUM INVESTMENT ApS | Company | 5.0% | 5.0% | 2020 |
Uddannelses- og Forskningsstyrelsen | Company | 15.0% | 15.0% | 2018 |
AACE IVS | Company | 5.0% | 5.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
QUORUM INVESTMENT ApS
Spraino Holding ApS Board members of Spraino Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Holm Hammer Hansen | Unofficial title | 0 companies |
| Thor Buch Grønlykke | Chief Executive Officer | 0 companies |
| Morten Johansen | Chairman | 0 companies |
| Lene Gerlach | Chairman | 0 companies |
| Carl Erik Jørgensen | Chairman | 0 companies |
| Lars Laurvig Haugaard | Chairman | 0 companies |
| Carsten Jerring Rønneby | Board of Directors | 0 companies |
| Peter Sørensen | Board of Directors | 0 companies |
| Peter Ladefoged | Chairman | 0 companies |